Tumor suppressor p53 is a nuclear transcription factor that blocks cell cycle progression and induces apoptosis. We have previously shown that the MCF7 resistance to the cytotoxic action of TNF correlates with p53 mutations. In the present study, we used a recombinant adenovirus carrying a wild-type p53 gene (Adwtp53) in order to investigate the eect of wt p53 transfer on modulation of cell resistance to the cytotoxic action of TNF. Our data indicate that infection of TNF resistant MCF7 cells (1001 and MCF7/Adr) with Adwtp53 resulted in the restoration of wt p53 expression and function as respectively revealed by the yeast assay and the induction of p53 inducible genes MDM2 and p21. Furthermore, the restoration of p53 function signi®cantly sensitized TNF resistant cells to TNF cytotoxic action. This correlated with a signi®cant down-regulation of cmyc in both TNF-resistant cell lines and a decrease of Retinoblastoma protein (Rb) in 1001 clone. In contrast, the eect of p53 seems to be independent from Bcl-2 and Bax protein level regulation. The present study suggests that the combination of TNF and Adwtp53 may be a potential strategy to sensitize mutant p53 TNF-resistant tumors to the cytotoxic action of this cytokine.
Introduction
Tumor necrosis factor (TNF) is a multifunctional cytokine that initiates a wide variety of biological responses. This factor acts as a host defence factor in immunological responses and plays a major role in tumor cell destruction mediated by cytotoxic T cells (Chouaib et al., 1991) . However, despite the antitumor eects of TNF, its eective application is strongly limited by acquisition or innate resistance of certain tumor cells to its cytotoxic action. Although locoregional administration of TNF partially resolved its systemic and toxic side eects (Lejeune et al., 1994) , resistance of some tumor cells to the cytotoxic action of TNF remains a drawback to its eective application. Therefore, understanding the molecular and biochemical mechanisms of tumor cell resistance to the cytocidal action of TNF may ultimately provide new approaches to enhance its therapeutic ecacy against human malignancies.
Several mechanisms have been reported to contribute to the cellular resistance to TNF-induced cell killing (Cai et al., 1997a; JaÈ attela et al., 1992; Liston et al., 1996; Opipari et al., 1992; Rothe et al., 1995; Wong and Goeddel, 1988; Zyad et al., 1994) . Recently, we have provided evidence for the existence of an association between the resistance of human breast adenocarcinoma cell line MCF7 to the cytotoxic action of TNF and the loss of p53 function (Cai et al., 1997b) . p53 is the most frequently mutated gene in human cancers (Hainaut et al., 1998) . Its mutations may interfere with some pathways responsible for apoptosis, including the transcription of some genes involved in the regulation of programmed cell death (PCD). It is clearly established that the nuclear phosphoprotein p53 is involved in the mediation of cell cycle checkpoints (Kastan et al., 1992) . Its induction after DNA damage and certain stress signals (Gottlieb and Oren, 1996) permits cell cycle control, by induction of apoptosis or growth arrest, depending on the cell type. p53 is a transcriptional factor which activity can be abrogated by mutations, almost all aecting the DNA-binding domain, abolishing or reducing the ability of p53 to bind DNA (Gottlieb and Oren, 1996) . This tumor suppressor gene probably induces a G1/S arrest through the combined inhibition of cyclin-dependent kinases and of DNA replication. The molecular mechanisms of p53 induced-apoptosis and its interaction with TNF cytotoxic pathways are less well characterized.
Among target genes transactivated by p53 are GADD45 gene, which is involved in cell cycle arrest (Kastan et al., 1992) and MDM2 gene which forms a regulatory feedback loop with p53 (Barak et al., 1993; Chen et al., 1994; Momand et al., 1992; Wu et al., 1993) . Another gene induced after exposure to DNA damaging agent and associated to wild-type p53 is p21 WAF1/CIP1 (El-Deiry et al., 1994; Harper et al., 1993) which encodes for an inhibitor of cyclin dependent kinase (Gu et al., 1993; Harper et al., 1993; Xiong et al., 1993) . Bcl-2 and Bax are known to be regulators of the apoptotic cascade and may serve as pores of unknown speci®city in the mitochondrial membrane. (Miyashita and Reed, 1995; Williams and Smith, 1993; Antonsson et al., 1997; Schendel et al., 1997; Zamzami et al., 1998) . While bax is activated by p53, bcl-2 gene is down-regulated by this tumor suppressor gene (Chiarugi et al., 1996) . Classically, bcl-2 has been demonstrated to have antiapoptotic properties while bax tends to enhance cell death.
c-myc and Rb proteins have also been reported to play a role in the control of cell survival. Although numerous studies have con®rmed that c-myc promotes cell cycle progression and cell transformation, there is con¯icting evidence supporting its role in apoptosis (Evan et al., 1992; Shi et al., 1992) . Accumulating evidence suggests that Rb plays an active role in antagonizing the death response and that preservation of Rb may protect against death by promoting arrest response to TNF signal (Janicke et al., 1996; Jeoung et al., 1995; Lopez-Marure et al., 1997; Tan et al., 1997) .
The present study shows that the transfer of wtp53 using an adenoviral vector sensitizes TNF resistant cells to TNF-induced cell death. Our results demonstrate that the mechanisms by which wt p53 regulates TNF sensitivity, correlate at least in part with the induction of p21 and MDM2, down-regulation of c- Figure 1 p53 functional analysis after Adwtp53 infection of TNF-sensitive MCF7 cells and TNF-resistant 1001 clone and MCF7Adr. (a) Cells (7610 3 cells/well) were incubated for 72 h with the indicated doses of recombinant TNF. Cell viability was measured using the crystal-violet assay as described in Materials and methods. Data presented are the means+s.d. of quadruplicate determinations. (b) Subcon¯uent cells were either non-infected or infected with 50 p.f.u. per cell of Adwtp53 and incubated for 20 h at 378C. Poly A RNA were extracted and p53 cDNA was generated by RT ± PCR. YIG 397 yeasts were co-transfected with crude PCR product, gapped repair pss16 and carrier DNA. Yeast colonies carrying p53 sequences were selected as described in Materials and methods. Colonies transfected with wt p53 were white and large and those transfected with mutated p53 were red and small. The number of red and white colonies were counted and expressed of a per cent of total colonies p53 and TNF cytotoxic action M Ameyar et al myc and degradation of Rb but are independent from bcl-2 and bax expression.
Results

Functional wt p53 expression following Adwtp53 infection of 1001 and MCF7/Adr cells
The role of p53 in the acquisition of cell resistance to the cytotoxic action of TNF is not well understood. To assess the in¯uence of wild-type p53 transfer on the regulation of cell sensitivity to TNF, we used a recombinant adenovirus carrying a wild-type p53 gene (Adwtp53). For this purpose, we used TNF-sensitive breast adenocarcinoma MCF7 cells and TNF-resistant derivatives 1001 clone and MCF7/ADR cells ( Figure  1a) . In a previous study, we have demonstrated a correlation between cell resistance to the cytotoxic action of TNF and p53 function (Cai et al., 1997b) . Using SSCP (single-strand conformation polymorphism) analysis and DNA sequencing, we have shown that while MCF7 has a wt p53 gene, both TNF resistant sublines (1001 and MCF7/Adr) derived from the parental MCF7 cells exhibit mutant p53. This includes in 1001 clone a point mutation P280K, known to be located in the p53 DNA-interaction site and in MCF7/Adr cells a point mutation at the splicing acceptor site of the upstream border of exon 5 resulting in a 21 pb deletion (Cai et al., 1997b) . To further con®rm the implication of p53 in TNF-induced cell death, we transferred wt p53 in TNF resistant cells expressing mutant p53 using an adenoviral vector. The eciency of Adwtp53 to induce the expression of wt p53 in infected cells was evaluated using the p53 functional assay (FASAY) based on yeast change color according to the p53 status. Using MCF7 cells known to express wild-type p53 as positive control, we showed that 91.5% of yeast colonies were white. Yeast colonies transfected with cDNA generated from non-infected 1001 clone and MCF7/ADR cells were red, while yeast colonies transfected with the cDNA generated from p53-infected cells were large and white, re¯ecting the expression of wt p53 (97.2% in MCF7/Adr and 95.2% in 1001 clone, respectively) ( Figure 1b ).
p21 and MDM2 expression following Adwtp53 infection
It is clearly established that expression of p53 induced p21 protein in cells undergoing G1 arrest or apoptosis (Deng et al., 1995; El-Deiry et al., 1993) . Another p53 inducible gene is MDM2 that functions in a feedback loop to inhibit the transcriptional activity of p53 (Wu et al., 1993) . To determine whether infection of TNF resistant cells with Adwtp53 leads to p21 and MDM2 induction, Western-blot analysis was performed. Figure 2a shows that infection of parental MCF7 cells with Adwtp53 induced an increase in p21 protein level. While a strong increase was observed in Adwtp53 infected MCF7/Adr (13-fold), a slight increase was detected in 1001 cells (2.4-fold). In addition, data shown in Figure 2b ) and treated or not with TNF (100 ng/ml). After 48 h, total cell lysates (30 mg) were subjected to 7.5% SDS ± PAGE. Blots were incubated with a monoclonal antibody to p21 (Ab-1, Oncogene Science) or MDM2 (IF2, Oncogene Science) and revealed with ECL reagent (Figure 3d ). It should be noted that infection with control adenovirus, used alone or in combination with TNF, had no signi®cant eect on the viability of cells.
Degradation of Rb following TNF Adwtp53 treatment of TNF-resistant cells
The Rb gene product is a nuclear phosphoprotein that participates in the transition between G1 and S phases of the cell cycle (Ewen, 1994) . Furthermore, Rb has been reported to interact with several cyclins including A, D and E (Hinds et al., 1992; Matsushime et al., 1992) as well as the transcriptional activator E2F (Bagchi et al., 1991; Chellappan et al., 1991) and MDM2 (Xiao et al., 1995) . Evidence has been provided indicating that Rb plays an active role in antagonizing the death response (Ewen, 1994) . We therefore asked whether the regulation of Rb gene expression was involved in wt p53-induced cell sensitization to the cytotoxic action of TNF. Western-blot analysis was performed to determine the status of Rb protein in TNF resistant cells before and after infection with Adwtp53 and concomitant treatment with TNF. As shown in Figure 4 , following Adwtp53 infection or TNF treatment of MCF7 cells, an underphosphorylation of Rb protein was observed. While Rb expression was not detectable in MCF7/Adr, in 1001 cells, the constitutive expression of Rb protein was signi®cantly more pronounced in these cells as compared to the parental MCF7 cells. When 1001 cells were infected with Adwtp53, a dramatic decrease in Rb protein expression was observed. This decrease was more pronounced following simultaneous treatment with Adwtp53 and TNF.
The increase in TNF sensitivity is correlated with down-regulation of c-myc expression
We have previously shown a constitutive overexpression of c-myc transcripts in TNF-resistant 1001 clone and MCF7/Adr cells, as compared to the parental MCF7 cells (Caignard et al., 1997) . Therefore, we investigated a possible relationship between Adwtp53-induced sensitization of TNF-resistant cells to the cytotoxic action of this cytokine and c-myc expression. Data of Figure 5 indicate that c-myc basal expression is more pronounced in TNF-resistant cells as compared to parental MCF7 cells. The data also indicate that while TNF-treatment of 1001 cells and MCF7/Adr cells led to no changes in c-myc level, infection of these cells with Adwtp53 induced a decrease in c-myc expression, which is more pronounced in MCF7/Adr cells. These data suggest that c-myc regulation may be involved in the modulation of TNF-sensitivity by wtp53.
The Adwtp53-induced sensitization of TNF-resistant cells to TNF does not involve bcl-2 and bax gene expression
It has been reported that bax and bcl-2 are involved in the regulation of tumor susceptibility to the cytotoxic , 1995) . Since p53 acts as transcriptional regulator of bcl-2 and bax gene expression in vitro and in vivo (Miyashita et al., 1994) , we asked whether the Adwtp53 induced sensitization of TNF resistant cells to the cytotoxic action of this cytokine involves modulation of these genes transcription. Western-blot analyses indicate that while Bax protein was expressed in all cell lines, Bcl-2 was expressed only in MCF7 parental cell line. Infection of TNF-resistant cells with Adwtp53 did not induce a decrease in Bcl-2 or an increase in Bax expression. These results emphasize the absence of correlation between Bcl-2/Bax expression and the cellular sensitivity to TNF cytotoxicity in human breast adenocarcinoma MCF7 cells and its TNFresistant derivatives.
Discussion
TNF has been shown to play a role in the killing of tumor cells by activated macrophages and cytotoxic T lymphocytes known to contribute to the early stages of antitumor surveillance. It was found to be capable of inducing tumor regression comparable to that of chemotherapeutic agents (Chouaib et al., 1991) . In contrast to the rapid progress that has been made in de®ning gene products capable of regulating TNFinduced cell death, the current understanding of the molecular mechanisms critical for tumor resistance to TNF and for subsequent tumor progression remains limited. Although a large body of evidence suggests that some oncogenes are involved in the regulation of tumor susceptibility to the cytotoxic action of TNF, our knowledge of the role of p53 in the control of apoptosis triggered by TNF remains largely unknown. In this context, we have previously shown that while MCF7 has a wt p53 gene, both TNF resistant sublines (1001 and MCF7/ADR) derived from the parental MCF7 cells exhibit mutant p53, resulting in loss of p53 transactivation functions. Furthermore, we have shown that impairment of wild-type p53 function may contribute to cell resistance towards the cytotoxic action of TNF and provided evidence that the disruption of wild-type p53 protein resulted in loss of the cytotoxic activity of TNF (Cai et al., 1997b) . It should be noted that MCF7 cells are caspase 3 de®cient (Janicke et al., 1998 and our unpublished results). Interestingly, while caspase 8 was expressed in TNF resistant cells, but not processed by TNF, the combination of TNF and Adwtp53 was ecient in inducing caspase 8 cleavage (data not shown). These observations may suggest that caspase 3 activity is not an essential requirement for the triggering of cell death in our experimental model but caspase 8 may play a role.
To further delineate the relationship between p53 and the apoptosis induced by TNF, we took advantage of our cell model based on the use of MCF7 and its TNF-resistant derivatives. In the present study, we . 30 mg of total cell lysates were subjected to 12% SDS ± PAGE, then monoclonal antibody to Bcl-2 (DAKO) or rabbit polyclonal to bax (Santa Cruz Biotechnology, Santa Cruz) was used p53 and TNF cytotoxic action M Ameyar et al used a replication-de®cient, recombinant, E1-E3 region deleted, p53 adenovirus to express wt p53 in the TNF resistant cells expressing mutant p53. The use of p53 functional assay indicates that the AdWtp53 was ecient in transducing the wt p53 transfer and subsequent gene expression. Interestingly, these studies clearly demonstrate that adenovirus-based transfer of wt p53 gene increased sensitivity of cells with mutant p53 to the cytotoxic eect of TNF. Having established the restoration of wt p53 and its function, and the subsequent induction of TNF apoptosis, we wished to examine the mechanistic analysis of p53-induced sensitization of TNF-resistant cells to the cytotoxic action of this cytokine.
We have ®rst shown that p53 transfer resulted in the expression of two p53 inducible genes, p21 and MDM2, re¯ecting the restoration of p53 function. Whether p21 induction is a causal component of the death pathway in MCF7 cells as previously reported (Gorospe et al., 1996) has to be determined. The induction of MDM2 may re¯ect a negative feedback regulation of p53 rather than a component of the apoptotic response.
Because the ratio of Bcl-2 and Bax proteins is thought to control relative susceptibility of cells to stimuli that induce apoptotic cell death (Oltvai et al., 1993) , we asked whether wtp53 induces decrease in bcl-2 and increase in bax expression in TNFresistant cells. Although it is clearly established that bcl-2 is an important regulator of apoptotic cascade, under our experimental conditions, the eect of sensitization by Adwtp53 does not seem to involve the Bcl-2 regulatory pathway. Our data are in agreement with previous reports indicating that overexpression of Bcl-2 in L929 mouse fibrosarcoma did not alter TNF sensitivity and that transfection of the Bcl-2 gene in MCF7 breast carcinoma did not reduce TNF sensitivity (Vanhaesebroeck and Van Roy, 1993 ). However, it should be noted that a con¯ictual situation remains with respect to the eect of this oncogenic protein in TNF-mediated cytotoxicity. Bax expression has been reported to be increased during p53-mediated human hematopoietic cell line CEM apoptosis and appears to be the most promising candidate for the primary p53 response gene in this cell death pathway (Geley et al., 1997) . However, we could not detect any change in Bax protein level following infection of TNF-resistant cells with AdWtp53. Thus, the regulation of cell susceptibility to TNF by wt p53 in TNF-resistant cells does not appear to be associated with diminution in bcl-2 or elevation in Bax protein levels and therefore ruling out the interference of wtp53 eect with the regulation of both genes in our experimental system.
The presence of a functional Rb has been related to prevention of apoptosis (Janicke et al., 1996; Jeoung et al., 1995; Lopez-Marure et al., 1997; Tan et al., 1997) and it clearly appears that regulation of apoptosis is tightly coordinated by Rb and p53. In addition, it has also become clear that Rb exhibits an anti-apoptotic function, since Rb-de®cient cells are more susceptible to apoptosis than cells with a fully functional Rb gene (Almasan et al., 1995) . The induced degradation of Rb during apoptosis supports the notion that Rb plays an active role in antagonizing the death response. In this regard, it has been suggested that in addition to its function in growth suppression, Rb may also play a role in the suppression of cell death. This is in agreement with a recent report showing that Rb is degraded in TNF-and CD95-induced cell death and that Rb is a target of the death eector proteases (Tan et al., 1997) , suggesting that degradation of Rb is required for cells to respond to TNF as a death signal. Our data suggest that the wt p53-induced increase in TNF sensitivity involves, at least in part, a Rb regulatory pathway in TNF resistant cells (clone 1001). p53 gene transfer-induced Rb protein modulation may involve an activation of caspase(s) cascade and consequently Rb cleavage or a modulation of phosphorylation status of Rb protein. This is in agreement with the reports of Gottlieb and Oren (1998) showing that p53 facilitates Rb cleavage in IL-3 deprived cells and suggesting that p53 makes cells permissive to Rb cleavage probably by controlling the potential activity of a Rb-cleaving caspase.
We have also attempted, in the course of this study to analyse the relationship between p53-induced sensitization to TNF and c-myc gene regulation. In a previous report, we provided evidence indicating that c-myc transcripts were constitutively overexpressed in TNF resistant cells. This suggests that c-myc may be a positive regulator of cell growth and that its activation may confer a growth advantage upon a tumor cell by promoting cell cycle progression and cell transformation. In a previous report, Klefstrom et al. (1997) have shown that an increased expression of the c-Myc oncoprotein strongly increases cellular sensitivity to TNF cytotoxicity in TNF-resistant rat1A ®broblasts, in a p53-dependent mechanism. Here, we show that one pathway by which TNF-resistant cells might escape apoptosis could be correlated with a dysregulation of c-myc expression and that down-regulation of c-myc correlates with sensitization to TNF-induced cell death. This discrepancy could be related to the cell type (human versus rat) and also to the status of the p53 in the cells used (wild versus mutated). How p53 induced down-regulation of c-Myc has to be further investigated. In this respect, it is also of interest to investigate the relationship between p53 and c-myc pathways in the control of the apoptotic process.
The ability of TNF to lyse neoplastic cells both in vitro and in vivo is of great interest in view of its potential role in cancer therapy (Chouaib et al., 1998; Lejeune et al., 1994) . Understanding of the complex actions of TNF and the possibility of manipulating its biological eects might provide new strategies in the use of this cytokine in cancer therapy. Our ®ndings also suggest that the status of the p53 gene, which is mutated in a high percentage of human cancers, may be an important determinant of the ecacy of treatment protocols based on the use of apoptosis-inducer anticancer agents. The results from this study suggest that wtp53 may be required in order to promote TNF-induced cell death and may help to achieve a signi®cant therapeutic index of TNF and to develop more eective therapeutic TNF intervention. 
Materials and methods
Reagents
Highly puri®ed (499%) recombinant TNF (speci®c activity 6.63610 6 U/mg protein) was kindly provided by Dr I Ap¯er (Bender Wien).
Cell lines and cell culture
MCF7Adr cells were originally isolated from the human breast-carcinoma MCF7 cell line by passing cells stepwise in increasing concentrations of adryamicine (Fairchild et al., 1987) . 1001 cells were derived from RA-1 cells transfected by p55 TNF-R cDNA as described (Cai et al., 1997a) . All cell lines were routinely cultured in RPMI 1640 medium containing 5% fetal calf serum, 1% penicillin-streptomycin, 1% L-glutamine at 378C in a humidi®ed atmosphere with 5% CO 2 .
Construction of recombinant adenovirus vector expressing wild-type p53 (Adwtp53) Adwtp53 was produced by in vivo homologous recombination in 293 cells after co-transfection of the linearized plasmid containing the left adenovirus ITR, wt p53 cDNA under the control of the SVE promoter (from SV40 virus), the pIX sequence of adenovirus and the adenovirus dl324 DNA digested with restriction enzyme ClaI. The resulting recombinant adenovirus is replication de®cient but is ampli®ed by infection of 293 cells which trans-complement for the deleted E1 region. Adwtp53 is cesium chloride centrifugation puri®ed, aliquoted in 20 ml of PBS containing 10% glycerol and stored at 7808C until use. Usually, 10 10 to 10 11 plaque forming units (p.f.u.) are obtained. Eciency of Adwtp53 to transfer and direct expression of wt p53 was analysed on p53 negative SAOS cells using speci®c monoclonal antibody 36 h after infection with Adwtp53.
Adenovirus infection of cells and expression of functional p53 analysis
The medium of subcon¯uent cells grown in 100 cm 2 petri dishes was removed and 50 or 100 p.f.u. cell of either Adwtp53 or empty adenovirus used as control was added in 1 ml of media. After 1 h incubation at 378C, 9 ml of complete medium were added to the cells. Cells were cultured for 72 h in the absence or presence of TNF. The expression of functional p53 in Adwtp53 infected cells was then analysed using the simple p53 functional assay in yeast (Flaman et al., 1995; Sharer and Iggo, 1992) . Brie¯y, polyadenylated RNAs were isolated from infected or uninfected cells and p53 complementary DNA (cDNA) was generated by RT ± PCR. Exponentially growing yeasts yIG397 are co-transformed by the lithium acetate procedure with crude PCR product, linearized vector for gap repair pSS16 and carrier DNA. Yeast colonies carrying p53 sequences recombined in the pSS16 plasmid (Leu+) were selected on synthetic minimal medium lacking leucine and containing minimal concentration of adenine. Yeast colonies expressing wt p53 were large and white, while those expressing mutant p53 were small and red because transactivation of the ADE2 gene was defective. The number of red and white yeast colonies was counted (at least a total of 100 colonies) and results were expressed as percentage of the total colonies of the same plate.
Determination of cell viability
Cells were seeded in 96-well plates (7.5610 4 cells/ml), and treated either with human recombinant TNF-a (100 ng/ml), or infected with Adwtp53 or control Ad, in the presence or absence of TNF. After incubation for 72 h at 378C, the medium was replaced with 0.5% crystal-violet solution. Plates were incubated for 10 min at room temperature, washed and viable crystal-violet-stained cells were lysed with 1% SDS. Absorbance (A), which was proportional to cell viability, was then measured at a wavelength of 540 nm. TNF-a mediated cell lysis was assessed by comparing the viability of untreated cells with that of treated cells using the following calculation: cell viability (%)=1006(A1/Ao); cell lysis (%)=17cell viability (%), where A1 and Ao were the absorbance obtained from treated and untreated cells, respectively. The main value of quadruplate was used for analysis. For cell cycle analysis, 10 6 cells were seeded in 100 mm plates and either treated with TNF or infected as described above. After incubation for 72 h at 378C, trypsinized cells were washed twice in PBS and ®xed in 70% ethanol for 1 h at 7208C. Cells were further washed twice in PBS, incubated with RNase (50 mg/ml) and propidium iodide (50 mg/ml) for 30 min at 378C, and subjected to¯ow cytometry analysis.
Western-blot analysis
Total cellular extracts were prepared by lysing cells in icecold buer (50 mM Tris pH 7.5, 150 mM Nacl, 1% Triton X-100, 1 mM phenylmethylsulfonyl¯uoride, 10 mg/ml aprotinin, and 10 mg/ml leupeptin). Equivalent protein extracts (30 or 50 mg) were denatured by boiling in SDS and 2-mercaptoethanol, separated by SDS ± PAGE and transferred onto nitrocellulose membrane. The eciency of the electrotransfer was assessed by Ponceau Red staining of the membranes. Blots were blocked overnight with TBS containing 5% nonfat dry milk or 5% BSA and probed with the appropriate antibody.
Abbreviations Rb: retinoblastoma; TNF: tumor necrosis factor; Adwtp53: adenovirus wild type p53; MDM2: murine double minute 2
